Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT02076347
NCT02076347CompletedNot Applicable

Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin

Ohio State University2 sites in 1 country489 target enrollmentStarted: February 2014Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
489
Locations
2
Primary Endpoint
Percentage of patients in each arm who obtain monitoring of vitamin B12 as recommended
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The purpose of this project is to compare two pharmacist-led population management strategies designed to increase the rate of appropriate monitoring of vitamin B12 and serum creatinine for patients taking metformin.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Screening
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •On Metformin for at least one year
  • •Activated patient portal for electronic messaging
  • •Patient of an attending physician at Ohio State General Internal Medicine
  • •No serum vitamin B12 and/or no serum creatinine measurement in the past year

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Percentage of patients in each arm who obtain monitoring of vitamin B12 as recommended

Time Frame: 6 months

Secondary Outcomes

  • Number of patients with newly identified vitamin B12 deficiency(6 months)
  • Percentage of patients with newly identified vitamin B12 deficiency who have prior evidence of anemia upon chart review(within 6 months)
  • Percentage of patients with newly identified vitamin B12 deficiency who have prior evidence of neuropathy upon chart review(within 6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kelli Barnes

Assistant Professor of Clinical Pharmacy

Ohio State University

Study Sites (2)

Loading locations...

Similar Trials

Completed
Not Applicable
Pharmacist Management of Paxlovid eVisitsCOVID-19Quality of Care
NCT06076863Kaiser Permanente2,478
Completed
Not Applicable
Comparative Effectiveness of Early Physical Therapy Versus Usual Care for Low Back PainLow Back Pain
NCT01556581Madigan Army Medical Center119
Unknown
Not Applicable
Efficacy Comparison Between Different Management Strategies for Consistent OAB in Patients With SVMs After SurgerySpinal Vascular Disorder NosOveractive Bladder
NCT03280316Xuanwu Hospital, Beijing100
Completed
Not Applicable
Comparison Between Two Strategies of Discharge Planning for the Reduction of Short Term Hospital ReadmissionsPatient Discharge
NCT03436940A.O.U. Città della Salute e della Scienza802
Recruiting
Phase 4
AWARE: Management of ADHD in Autism Spectrum DisorderADHDAutism Spectrum Disorder
NCT05916339Daniel Coury500